Über uns

NFDI4Health hat zum Ziel, ein umfassendes Inventar deutscher epidemiologischer, Public-Health- und klinischer Studiendaten aufzubauen. Die Erfassung und Analyse dieser Daten sind wesentlich zur Entwicklung neuer Therapien, übergreifender Versorgungsansätze und präventiver Maßnahmen. 

Personenbezogene Gesundheitsdaten verlangen einen besonderen Schutz. Erklärtes Ziel von NFDI4Health ist es daher, Sicherheit und Nutzbarkeit zu vereinen. Das Konsortium setzt sich aus 17 Partnern verschiedener Fachdisziplinen zusammen. Insgesamt 48 namhafte Institutionen aus dem Gesundheitsbereich sind beteiligt.

Mastodon
Webseite

Ziele

Die NFDI soll die Datenbanken von Wissenschaft und Forschung systematisch erschließen, nachhaltig sichern, zugänglich machen und (inter-)national vernetzen. Darin eingebettete Ziele von NFDI4Health sind:

  •  Auffindbarkeit von und Zugang zu strukturierten Gesundheitsdaten ermöglichen.
  • Föderalen Rahmen für Datenhaltungsorganisationen erhalten.
  • Austausch und Verknüpfung von personenbezogenen Daten unter Wahrung des Datenschutzes ermöglichen.
  • Automatisierte Dienste (z.B. Suche, Analysetools) etablieren.
  • Interoperabilität und Wiederverwendbarkeit der Daten etablieren und verbessern.
  • Anwendungsfallorientierte Zusammenarbeit zwischen Forschungsgemeinschaften fördern.

Aufgabenbereich

Prof. Dr. Juliane Fluck

Sprecherin des Konsortiums

(Quelle: ZB MEd/M. Gloger)

(Mit-)Antragstellende Institutionen und (Co-)Sprecher:innen:
  • Prof. Dr. Wolfgang Ahrens – BIPS, Bremen
  • Prof. Dr. Iris Pigeot – BIPS, Bremen
  • Prof. Dr. Hajo Zeeb – BIPS, Bremen
  • Prof. Dr. Fabian Prasser – Charité/BIH, Berlin
  • Prof. Dr. Sylvia Thun – Charité/BIH, Berlin
  • Prof. Dr. Matthias Schulze – DIfE, Nuthetal
  • Dr. Oya Beyan – Fraunhofer, Fraunhofer FIT, Aachen
  • Prof. Dr. Holger Fröhlich – Fraunhofer, Fraunhofer SCAI, St. Augustin
  • Prof. Dr.-Ing. Horst Hahn – Fraunhofer, Fraunhofer MEVIS, Bremen
  • Martin Golebiewski – HITS, Heidelberg
  • PD Dr. Wolfgang Müler – HITS, Heidelberg
  • PD Dr. Sebastian Klammt – KKSN, Berlin
  • Prof. Dr. Tobias Pischon – MDC, Berlin
  • PD Dr. L. Grabenheinrich – RKI, Berlin
  • Prof. Dr. Lothar H. Wieler – RKI, Berlin
  • Juliane Gehrke – TMF, Berlin
  • Sebastian C. Semmler – TMF, Berlin
  • Prof. Dr. Ute Nöthlings – U Bonn, Bonn
  • Prof. Dr. Benedikt Buchner – U Bremen, Bremen
  • Ralph Depping – U Cologne, USB, Cologne
  • Dr. Jens Dierkes – U Cologne, USB, Cologne
  • Dr. Hubertus Neuhaus – U Cologne, USB, Cologne
  • Dr. Oana Brosteanu – U Leipzig, ZKS, Leipzig
  • Matthias Löbe – U Leipzig, IMISE, Leipzig
  • Prof. Dr. Markus Löffler – U Leipzig, IMISE, LIFE, ZKS, Leipzig
  • Dr. Frank Meineke – U Leipzig, IMISE, Leipzig
  • Prof. Dr.-Ing. Toralf Kirsten – UAS Mittweida, Mittweida
  • Dr. Harald Kusch – UM Göttingen, Göttingen
  • Prof. Dr. Ulrich Sax – UM Göttingen, Göttingen
  • Prof. Dr. Carsten Oliver Schmidt – UM Greifswald, Greifswald
  • Prof. Dr. Dagmar Waltemath – UM Greifslwald, Greifswald
  • Johannes Darms – ZB MED, Cologne
  • Birte Lindstädt – ZB MED, Cologne
  • Leibniz Institute for Prevention Research and Epidemiology – BIPS
  • Charité – Universitätsmedizin Berlin, Berlin Institute of Health
  • German Institute for Human Nutrition Potsdam-Rehbrücke
  • Fraunhofer-Gesellschaft (Fraunhofer Institute for Applied Information Technology FIT; Fraunhofer Institute for Digital Medicine MEVIS; Fraunhofer Institute for Algorithms & Scientific Computing SCAI)
  • Heidelberg Institute for Theoretical Studies (HITS gGmbH)
  • Network of Coordinating Centres for Clinical Trials – KKSN e.V.
  • Max Delbrück Center for Molecular Medicine in the Helmholtz Association
  • Robert Koch Institute
  • Technology, Methods, and Infrastructure for Networked Medical Research
  • University of Bonn (Institute of Nutrition and Food Sciences)
  • University of Bremen (Institute for Information, Health and Medical Law (IGMR))
  • University of Cologne (University and City Library of Cologne (USB))
  • University of Leipzig (Institute for Medical Informatics, Statistics and Epidemiology (IMISE); LIFE-Research Centre for Civilisation Diseases; Centre for Clinical Trials (ZKS))
  • University of Applied Sciences Mittweida
  • University of Göttingen (University Medical Center)
  • University Medicine Greifswald (Institute for Community Medicine)

ZB MED – Information Centre for Life Sciences

Antragsstellende Institution

Beteiligte Institutionen
  • AGENS – Working group on the collection and use of secondary data (Dr. Enno Swart) – Magdeburg
  • Brain Simulation Section at the Department Neurology, Charité Universitätsmedizin Berlin (Prof. Dr. Petra Ritter) – Berlin
  • Center for Biotechnology (CeBiTec) of Bielefeld University (Prof. Dr. Alfred Pühler) – Bielefeld
  • Center for Clinical Studies Regensburg (Prof. Dr. Michael Koller) – Regensburg
  • Center for Clinical Trials Essen (Prof. Dr. Karl-Heinz Jöckel) – Essen
  • Center for Clinical Trials Münster, University of Münster (Prof. Dr. Dr. Andreas Faldum) – Münster
  • Clinical Trials Centre Cologne, University Cologne (Alexandra Nieß) – Cologne
  • Clinical Trials Unit, University Medical Center Freiburg (Dr. Britta Lang) – Freiburg
  • Coordination Center for Clinical Studies in Magdeburg, Otto-von Guericke University Magdeburg (Dr. Antje Wiede) – Magdeburg
  • Coordination Center for Clinical Trials Düsseldorf, Düsseldorf University Clinic (Henrike Kolbe) – Düsseldorf
  • CoRe-Net (BMBF Infrastructure Network, University of Cologne) (Dr. Nadine Scholten) – Cologne
  • DIN German Institute for Standardization (Rüdiger Marquardt) – Berlin
  • Federal Centre of Health Education (BZgA) (Dr. Heidrun M. Thaiss) – Cologne
  • German Association for Medical Informatics, Biometry and Epidemiology (GMDS) (Prof. Dr. Andreas Stang) – Cologne
  • German Association of Medical Faculties (MFT) (Dr. Frank Wissing) – Berlin
  • German Cancer Research Center (DKFZ), Division of Cancer Epidemiology (Prof. Dr. Rudolf Kaaks) – Heidelberg
  • German Consortium of Hereditary Breast and Ovarian Cancer (Prof. Dr. Rita Schmutzler) – Cologne
  • German Data Forum (RatSWD) (Prof. Regina T. Riphahn, PhD) – Berlin
  • Federal Institute for Drugs and Medical Devices (BfArM) (Dr. Steffen Heß) – Bonn
  • German Network for Evidence-based Medicine (DNEbM) (Prof. Dr. Andreas Sönnichsen) – Berlin – 
  • German Nutrition Society (DGE) (Dr. Johanna Conrad) – Bonn
  • German Public Health Association (DGPH) (Prof. Dr. Ansgar Gerhardus) – Bochum
  • German Region of the International Biometric Society (IBS-DR) (Prof. Dr. Werner Brannath) – Hanover
  • German Society for Drug Utilization Research and Drug Epidemiology (GAA) (PD Dr. Katrin Farker) – Jena
  • German Society for Epidemiology (DGEpi) (Prof. Dr. Dietrich Rothenbacher)- Ulm
  • German Society for Occupational and Environmental Medicine (DGAUM) (Dr. Thomas Nesseler) – Munich
  • German Society of Medical Sociology (DGMS) (Prof. Dr. Nico Dragano) – Düsseldorf
  • German Society of Social Medicine and Prevention (DGSMP) (Prof. Dr. Susanne Moebus) – Hamburg
  • Gutenberg Health Study, University Medical Center of the Johannes Gutenberg-University Mainz (Prof. Dr. Philipp Wild)  – Mainz
  • Hamburg Cancer Registry (Dr. Stefan Hentschel, Dr. Alice Nennecke) – Hamburg
  • Hamburg City Health Study, University Medical Center Hamburg-Eppendorf (UKE) (Prof. Dr. Stefan Blankenberg, Dr. Annika Jagodzinski) – Hamburg
  • Heinz Nixdorf Recall and Multigeneration Study, Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), University Hospital Essen (Prof. Dr. Karl-Heinz Jöckel) – Essen
  • Institute for Prevention and Occupational Medicine of the German Social Accident Insurance Institute of the Ruhr University Bochum (IPA) (Prof. Dr. Thomas Behrens) – Bochum
  • Institute of Biostatistics and Clinical Research, University of Münster (Prof. Dr. Dr. Andreas Faldum) – Münster
  • Institute of Epidemiology, Helmholtz Zentrum München (HMGU) (Prof. Dr. Annette Peters, Dr. Marie Standl) – Munich
  • Institute of Medical Epidemiology, Biometrics and Informatics (IMEBI), Medical Faculty, Martin Luther University Halle-Wittenberg (Prof. Dr. Rafael Mikolajczyk) – Halle (Saale)
  • Institute of Social Medicine and Health Economics, Faculty of Medicine, Otto-von-Guericke University Magdeburg (Dr. Enno Swart) – Magdeburg
  • Leibniz Institute for Resilience Research (LIR) (Univ.-Prof. Dr. Klaus Lieb, Univ.-Prof. Dr. Beat Lutz) – Mainz 
  • Max Rubner-Institute (MRI) (Prof. Dr. Pablo Steinberg) – Karlsruhe
  • Medical School OWL, Bielefeld University (Prof. Dr. Claudia Hornberg) – Bielefeld
  • mediStatistica Dr. Burkhard Haastert (Dr. Burkhard Haastert) – Neuenrade – 
  • NAKO Health Study, German National Cohort (Prof. Dr. Annette Peters) – Heidelberg 
  • OFFIS Institute for Information Technology (Prof. Dr. Susanne Boll-Westermann) – Oldenburg 
  • PMV Forschungsgruppe, University of Cologne (Ingo Meyer) – Cologne
  • School of Medicine and Health Sciences, Carl von Ossietzky-University Oldenburg (Prof. Dr. Hans Gerd Nothwang) – Oldenburg
  • Society of Epidemiological Cancer Registries in Germany (GEKID) (Prof. Dr. Alexander Katalinic) – Saarbrücken
  • University Computing Centre, University of Greifswald (Prof. Dr. Johanna Eleonore Weber) – Greifswald

    Prof. Dr. Juliane Fluck

    Sprecherin des Konsortiums (Quelle: ZB MEd/M. Gloger)

    ZB MED – Information Centre for Life Sciences

    Antragsstellende Institution

    (Mit-)Antragstellende Institutionen und (Co-)Sprecher:innen:
    • Prof. Dr. Wolfgang Ahrens – BIPS, Bremen
    • Prof. Dr. Iris Pigeot – BIPS, Bremen
    • Prof. Dr. Hajo Zeeb – BIPS, Bremen
    • Prof. Dr. Fabian Prasser – Charité/BIH, Berlin
    • Prof. Dr. Sylvia Thun – Charité/BIH, Berlin
    • Prof. Dr. Matthias Schulze – DIfE, Nuthetal
    • Dr. Oya Beyan – Fraunhofer, Fraunhofer FIT, Aachen
    • Prof. Dr. Holger Fröhlich – Fraunhofer, Fraunhofer SCAI, St. Augustin
    • Prof. Dr.-Ing. Horst Hahn – Fraunhofer, Fraunhofer MEVIS, Bremen
    • Martin Golebiewski – HITS, Heidelberg
    • PD Dr. Wolfgang Müler – HITS, Heidelberg
    • PD Dr. Sebastian Klammt – KKSN, Berlin
    • Prof. Dr. Tobias Pischon – MDC, Berlin
    • PD Dr. L. Grabenheinrich – RKI, Berlin
    • Prof. Dr. Lothar H. Wieler – RKI, Berlin
    • Juliane Gehrke – TMF, Berlin
    • Sebastian C. Semmler – TMF, Berlin
    • Prof. Dr. Ute Nöthlings – U Bonn, Bonn
    • Prof. Dr. Benedikt Buchner – U Bremen, Bremen
    • Ralph Depping – U Cologne, USB, Cologne
    • Dr. Jens Dierkes – U Cologne, USB, Cologne
    • Dr. Hubertus Neuhaus – U Cologne, USB, Cologne
    • Dr. Oana Brosteanu – U Leipzig, ZKS, Leipzig
    • Matthias Löbe – U Leipzig, IMISE, Leipzig
    • Prof. Dr. Markus Löffler – U Leipzig, IMISE, LIFE, ZKS, Leipzig
    • Dr. Frank Meineke – U Leipzig, IMISE, Leipzig
    • Prof. Dr.-Ing. Toralf Kirsten – UAS Mittweida, Mittweida
    • Dr. Harald Kusch – UM Göttingen, Göttingen
    • Prof. Dr. Ulrich Sax – UM Göttingen, Göttingen
    • Prof. Dr. Carsten Oliver Schmidt – UM Greifswald, Greifswald
    • Prof. Dr. Dagmar Waltemath – UM Greifslwald, Greifswald
    • Johannes Darms – ZB MED, Cologne
    • Birte Lindstädt – ZB MED, Cologne
    • Leibniz Institute for Prevention Research and Epidemiology – BIPS
    • Charité – Universitätsmedizin Berlin, Berlin Institute of Health
    • German Institute for Human Nutrition Potsdam-Rehbrücke
    • Fraunhofer-Gesellschaft (Fraunhofer Institute for Applied Information Technology FIT; Fraunhofer Institute for Digital Medicine MEVIS; Fraunhofer Institute for Algorithms & Scientific Computing SCAI)
    • Heidelberg Institute for Theoretical Studies (HITS gGmbH)
    • Network of Coordinating Centres for Clinical Trials – KKSN e.V.
    • Max Delbrück Center for Molecular Medicine in the Helmholtz Association
    • Robert Koch Institute
    • Technology, Methods, and Infrastructure for Networked Medical Research
    • University of Bonn (Institute of Nutrition and Food Sciences)
    • University of Bremen (Institute for Information, Health and Medical Law (IGMR))
    • University of Cologne (University and City Library of Cologne (USB))
    • University of Leipzig (Institute for Medical Informat¬ics, Statistics and Epidemiology (IMISE); LIFE-Research Centre for Civilisation Diseases; Centre for Clinical Trials (ZKS))
    • University of Applied Sciences Mittweida
    • University of Göttingen (University Medical Center)
    • University Medicine Greifswald (Institute for Community Medicine)
      Beteiligte Institutionen
      • AGENS – Working group on the collection and use of secondary data (Dr. Enno Swart) – Magdeburg
      • Brain Simulation Section at the Department Neurology, Charité Universitätsmedizin Berlin (Prof. Dr. Petra Ritter) – Berlin
      • Center for Biotechnology (CeBiTec) of Bielefeld University (Prof. Dr. Alfred Pühler) – Bielefeld
      • Center for Clinical Studies Regensburg (Prof. Dr. Michael Koller) – Regensburg
      • Center for Clinical Trials Essen (Prof. Dr. Karl-Heinz Jöckel) – Essen
      • Center for Clinical Trials Münster, University of Münster (Prof. Dr. Dr. Andreas Faldum) – Münster
      • Clinical Trials Centre Cologne, University Cologne (Alexandra Nieß) – Cologne
      • Clinical Trials Unit, University Medical Center Freiburg (Dr. Britta Lang) – Freiburg
      • Coordination Center for Clinical Studies in Magdeburg, Otto-von Guericke University Magdeburg (Dr. Antje Wiede) – Magdeburg
      • Coordination Center for Clinical Trials Düsseldorf, Düsseldorf University Clinic (Henrike Kolbe) – Düsseldorf
      • CoRe-Net (BMBF Infrastructure Network, University of Cologne) (Dr. Nadine Scholten) – Cologne
      • DIN German Institute for Standardization (Rüdiger Marquardt) – Berlin
      • Federal Centre of Health Education (BZgA) (Dr. Heidrun M. Thaiss) – Cologne
      • German Association for Medical Informatics, Biometry and Epidemiology (GMDS) (Prof. Dr. Andreas Stang) – Cologne
      • German Association of Medical Faculties (MFT) (Dr. Frank Wissing) – Berlin
      • German Cancer Research Center (DKFZ), Division of Cancer Epidemiology (Prof. Dr. Rudolf Kaaks) – Heidelberg
      • German Consortium of Hereditary Breast and Ovarian Cancer (Prof. Dr. Rita Schmutzler) – Cologne
      • German Data Forum (RatSWD) (Prof. Regina T. Riphahn, PhD) – Berlin
      • Federal Institute for Drugs and Medical Devices (BfArM) (Dr. Steffen Heß) – Bonn
      • German Network for Evidence-based Medicine (DNEbM) (Prof. Dr. Andreas Sönnichsen) – Berlin –
      • German Nutrition Society (DGE) (Dr. Johanna Conrad) – Bonn
      • German Public Health Association (DGPH) (Prof. Dr. Ansgar Gerhardus) – Bochum
      • German Region of the International Biometric Society (IBS-DR) (Prof. Dr. Werner Brannath) – Hanover
      • German Society for Drug Utilization Research and Drug Epidemiology (GAA) (PD Dr. Katrin Farker) – Jena
      • German Society for Epidemiology (DGEpi) (Prof. Dr. Dietrich Rothenbacher)- Ulm
      • German Society for Occupational and Environmental Medicine (DGAUM) (Dr. Thomas Nesseler) – Munich
      • German Society of Medical Sociology (DGMS) (Prof. Dr. Nico Dragano) – Düsseldorf
      • German Society of Social Medicine and Prevention (DGSMP) (Prof. Dr. Susanne Moebus) – Hamburg
      • Gutenberg Health Study, University Medical Center of the Johannes Gutenberg-University Mainz (Prof. Dr. Philipp Wild)  – Mainz
      • Hamburg Cancer Registry (Dr. Stefan Hentschel, Dr. Alice Nennecke) – Hamburg
      • Hamburg City Health Study, University Medical Center Hamburg-Eppendorf (UKE) (Prof. Dr. Stefan Blankenberg, Dr. Annika Jagodzinski) – Hamburg
      • Heinz Nixdorf Recall and Multigeneration Study, Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), University Hospital Essen (Prof. Dr. Karl-Heinz Jöckel) – Essen
      • Institute for Prevention and Occupational Medicine of the German Social Accident Insurance Institute of the Ruhr University Bochum (IPA) (Prof. Dr. Thomas Behrens) – Bochum
      • Institute of Biostatistics and Clinical Research, University of Münster (Prof. Dr. Dr. Andreas Faldum) – Münster
      • Institute of Epidemiology, Helmholtz Zentrum München (HMGU) (Prof. Dr. Annette Peters, Dr. Marie Standl) – Munich
      • Institute of Medical Epidemiology, Biometrics and Informatics (IMEBI), Medical Faculty, Martin Luther University Halle-Wittenberg (Prof. Dr. Rafael Mikolajczyk) – Halle (Saale)
      • Institute of Social Medicine and Health Economics, Faculty of Medicine, Otto-von-Guericke University Magdeburg (Dr. Enno Swart) – Magdeburg
      • Leibniz Institute for Resilience Research (LIR) (Univ.-Prof. Dr. Klaus Lieb, Univ.-Prof. Dr. Beat Lutz) – Mainz
      • Max Rubner-Institute (MRI) (Prof. Dr. Pablo Steinberg) – Karlsruhe
      • Medical School OWL, Bielefeld University (Prof. Dr. Claudia Hornberg) – Bielefeld
      • mediStatistica Dr. Burkhard Haastert (Dr. Burkhard Haastert) – Neuenrade –
      • NAKO Health Study, German National Cohort (Prof. Dr. Annette Peters) – Heidelberg
      • OFFIS Institute for Information Technology (Prof. Dr. Susanne Boll-Westermann) – Oldenburg
      • PMV Forschungsgruppe, University of Cologne (Ingo Meyer) – Cologne
      • School of Medicine and Health Sciences, Carl von Ossietzky-University Oldenburg (Prof. Dr. Hans Gerd Nothwang) – Oldenburg
      • Society of Epidemiological Cancer Registries in Germany (GEKID) (Prof. Dr. Alexander Katalinic) – Saarbrücken
      • University Computing Centre, University of Greifswald (Prof. Dr. Johanna Eleonore Weber) – Greifswald